Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.
Stanford University Medical Center - $35,589
$35,589.00
October 2012
A Combinatorial Approach to Target Cellular Subpopulations in DIPG
Texas Children's Cancer Center - $100,000
$100,000.00
October 2012
Preclinical Evaluation of Novel BMI-1 Inhibitors In Vivo in Intra-Brainstem Orthotopic Xenograft Mouse Models
St. Jude's Children's Research Hospital - $15,000
$15,000.00
October 2012
Establishment and Characterization of Renewable Tissue Resources for DIPG Research
DIPG Registry - $219,000
$219,000.00
January 2012
Establishment of an International DIPG Registry
Texas Children's Cancer Center - $100,000
$100,000.00
November 2011
Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001
Duke University - $82,049
$82,049.00
November 2011
Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody
Doernbecher Children's Hospital - $100,000
$100,000.00
November 2011
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
Sydney Children's Hospital - $100,000
$100,000.00
August 2011
Robotic screening for novel therapies for diffuse pontine gliomas
St. Jude's Children's Research Hospital - $35,000
$35,000.00
September 2010
PI3K signaling effectors in DIPG
Cincinnati Children's Hospital - $35,000
$35,000.00
September 2010
Establishment of a pre-clinical model for pediatric glioblastoma
Cincinnati Children's Hospital - $75,000
$75,000.00
March 2010
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Weill Cornell Medical College - $91,740
$91,740.00
March 2010
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
St. Jude's Children's Research Hospital - $10,000
$10,000.00
July 2009
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
Cincinnati Children's Hospital - $50,000
$50,000.00
July 2009
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $50,000
$50,000.00
July 2009
Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.